Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"Undetermined"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22IgA%22&type=Subject&filter%5B%5D=language%3A%22Undetermined%22
/vufind/Search/Results?lookfor=%22IgA%22&type=Subject&filter%5B%5D=language%3A%22Undetermined%22
Search /vufind/Search2/Results?lookfor=%22IgA%22&type=Subject&filter%5B%5D=language%3A%22Undetermined%22
PubPharm (15)
1
IgA nephropathy steroid gargling therapy trail : Validation of the safety and efficacy of steroid gargling therapy in IgA nephropathy - IGANGARGLE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
IgA nephropathy steroid gargling therapy trail : Validation of the safety and efficacy of steroid gargling therapy in IgA nephropathy - IGANGARGLE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
The Relevance of Nutrition for Pediatric Allergy and Immunity
Erschienen: Basel,
MDPI - Multidisciplinary Digital Publishing Institute,
2023
von
Van Neerven, R.
|
Ruinemans-Koerts, J.
Wird geladen...
4
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) : A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Ravulizumab in LN or IgAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Sprache: Unbestimmt
Medienart
15
E-Ressourcen
14
Aufsätze
14
E-Artikel
1
Bücher
1
E-Books
Alle anzeigen ...
weniger ...
Zeitschriftentitel
14
WHO International Clinical Trials Registry Plat...
Thema
14
610
12
Study Type: Interventional
10
Recruitment Status: Authorised-recruitment may ...
8
Phase: Phase 2
6
Medical Condition: Lupus Nephritis (LN)Immunogl...
4
Recruitment Status: Not yet recruiting
2
Medical Condition: IgA nephropathy
2
Medical Condition: IgA nephropathy IgA nephropa...
2
Medical Condition: Lupus Nephritis (LN) - Immun...
2
Medical Condition: MedDRA version: 19.1Level: P...
2
Phase: Other
2
Phase: Phase 3
2
Study Type: Observational
1
Asthma
1
Der p 1
1
IgA deficiency
1
IgE sensitization
1
Medicine and Nursing
1
Mediterranean diet
1
NICE birth cohort
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
11
2020-
4
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...